Inside the box: Acoustic ejection mass spectrometry for drug discovery by Kirsten Craven | 0 CommentsOn average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.
Want to accelerate your drug discovery workflow? by Kirsten Craven | 0 CommentsBringing a new drug to market is a costly and complex process. With potentially hundreds of thousands of new compounds to screen during drug discovery, sample throughput is a common bottleneck for pharmaceutical companies. So how do you overcome this barrier?
What has the Echo® MS system done for the pharma industry? (And don’t just take our word for it!) by Kirsten Craven | 0 CommentsSCIEX was very proud to have an illustration of the Acoustic Ejection Mass Spectrometry (AEMS) technology that powers the Echo® MS system on the front cover of the Journal of the American Society for Mass Spectrometry in January 2023. The associated article—Ultrahigh-Throughput Intact Protein Analysis with Acoustic Ejection Mass Spectrometry—was co-authored by scientists from SCIEX and Merck.
5 Reasons to choose the Echo® MS system for high-throughput drug discovery by Kirsten Craven | 0 CommentsHave you thought about introducing new technology into your high-throughput drug discovery lab? Here are 5 reasons the Echo® MS system could make a difference for you.
Inside the box: Acoustic ejection mass spectrometry for drug discovery by Kirsten Craven | Blogs, Discovery, Echo MS, Pharma, QA/QCOn average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.
Want to accelerate your drug discovery workflow? by Kirsten Craven | Blogs, Echo MS, PharmaBringing a new drug to market is a costly and complex process. With potentially hundreds of thousands of new compounds to screen during drug discovery, sample throughput is a common bottleneck for pharmaceutical companies. So how do you overcome this barrier?
What has the Echo® MS system done for the pharma industry? (And don’t just take our word for it!) by Kirsten Craven | Blogs, Discovery, Echo MS, PharmaSCIEX was very proud to have an illustration of the Acoustic Ejection Mass Spectrometry (AEMS) technology that powers the Echo® MS system on the front cover of the Journal of the American Society for Mass Spectrometry in January 2023. The associated article—Ultrahigh-Throughput Intact Protein Analysis with Acoustic Ejection Mass Spectrometry—was co-authored by scientists from SCIEX and Merck.
5 Reasons to choose the Echo® MS system for high-throughput drug discovery by Kirsten Craven | Blogs, Discovery, Echo MS, PharmaHave you thought about introducing new technology into your high-throughput drug discovery lab? Here are 5 reasons the Echo® MS system could make a difference for you.
Top 7 Echo® MS system customer questions—answered by Neil Walsh | Biopharma, Blogs, Echo MS, Pharma You asked, we answered! With analysis speeds of at least 1 sample per second, the Echo® MS system has created a buzz in the industry. This is up to 50x faster than conventional LC-MS/MS. This revolutionary tool for drug discovery and development has led to...
Eliminate chick culling with innovative technology by Craig Butt | Blogs, Food / Beverage, Food and BeverageWhile it sometimes seems questionable whether humanity and modern technology can coexist, technological advances in science can help pave the way to more compassionate business practices.
An interview from the Science Explorer about the Echo® MS system by SCIEX Community | Blogs, Echo MS, PharmaThe Science Explorer interviews Neil Walsh from SCIEX to discuss the significant application areas of the Echo® MS System and what makes this system so attractive to biopharmaceutical laboratories.
The Echo® MS system: Is it reproducible? Yes… yes… yes! by Neil Walsh | Biopharma, Blogs, Echo MS, PharmaThe Echo® MS System is an exciting new platform that dramatically speeds sample analysis for quantitative MS studies. Because of its unique and innovative technology, the system can analyze samples faster than ever before—but without the need for LC.
Scale it up! The Echo® MS System delivers unprecedented levels of productivity by Neil Walsh | Biopharma, Blogs, Echo MS, PharmaImagine the productivity gains your lab could achieve with a technology that not only analyzes samples up to 50x faster than conventional quantitative LC-MS, but also eliminates tedious sample preparation, time-consuming LC method development and chromatographic run...
How fast is fast? The Echo® MS System sets the record by Neil Walsh | Biopharma, Blogs, Echo MS, PharmaHow fast is fast? Cheetahs. Usain Bolt. Tachyons. The Echo® MS system. What do these things have in common? They’re all fast. REALLY fast. In fact, they’re the fastest in their categories: the fastest land mammal, the fastest human sprinter, the fastest subatomic...
Ever thought of breaking the high-throughput sound barrier for drug discovery? by SCIEX Community | Blogs, PharmaWouldn’t it be great if we really could “get time back” or even “buy time”? When developing pharmaceuticals, it takes years to bring a new therapy to the market due to the linear nature of the process. As the saying goes, “Time waits for no one.” But what if we could...